Charcoal, Activated

Charcoal, Activated

SCHEMBL1484029

C=CC(=C)C.[C].[C]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Charcoal, Activated SCHEMBL30289892 1.00 ALDH1A1 (0.91)
Charcoal, Activated SCHEMBL318468 1.00
SCHEMBL1331930 0.95
SCHEMBL20661241 0.95 ALDH1A1 (1.00)
SCHEMBL14855 0.95
SCHEMBL322832 0.95 ALDH1A1 (1.00)
SCHEMBL7091146 0.91
SCHEMBL11504181 0.91
Ethylene SCHEMBL8752751 0.91
Bromide SCHEMBL8198603 0.91 ALDH1A1 (0.91)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130137760-A1 GAMBOGIC AMINE, A SELECTIVE TRKA AGONIST WITH NEUROPROTECTIVE ACTIVITY EMORY UNIVERSITY (US) 2013-05-30 US disclosed
US-20110077293-A1 GAMBOGIC AMINE, A SELECTIVE TrkA AGONIST WITH NEUROPROTECTIVE ACTIVITY EMORY UNIVERSITY (US) 2011-03-31 US disclosed
CN-101821262-A Gambogic amide, a kind of selectivity TrkA agonist with neuroprotective activity UNIV EMORY 2010-09-01 CN disclosed
EP-1180991-B1 GAMBOGIC ACID DERIVATIVES AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS CYTOVIA INC (US) 2010-05-19 EP disclosed
US-7622497-B2 Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis CYTOVIA, INC. (US) 2009-11-24 US disclosed
US-20090163577-A1 METHODS AND COMPOSITIONS FOR ANTAGONIZING ANTI-APOPTOTIC Bcl-2-FAMILY PROTEINS BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2009-06-25 US disclosed
WO-2009036068-A2 GAMBOGIC AMINE, A SELECTIVE TRKA AGONIST WITH NEUROPROTECTIVE ACTIVITY EMORY UNIVERSITY (US) 2009-03-19 WO disclosed
WO-2008148008-A1 HIGH THROUGHPUT BIOASSAY FOR IDENTIFYING SELECTIVE TRKA RECEPTOR AGONISTS, AND GAMBOGIC AMIDE, A SELECTIVE TRKA AGONIST WITH NEUROPROTECTIVE ACTIVITY EMORY UNIVERSITY (US) 2008-12-04 WO disclosed
US-20070093456-A1 Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis CYTOVIA, INC. 2007-04-26 US disclosed
US-7176234-B2 Anticancer agents; side effect reduction CYTOVIA, INC. (US) 2007-02-13 US disclosed
EP-1180991-A4 GAMBOGIC ACID, ANALOGS AND DERIVATIVES AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS CYTOVIA INC (US) 2005-10-12 EP disclosed
EP-1562598-A2 DERIVATIVES OF GAMBOGIC ACID AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS Cytovia, Inc. (US) 2005-08-17 EP disclosed
WO-2005060663-A2 DERIVATIVES OF GAMBOGIC ACID AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS CYTOVIA, INC. (US) 2005-07-07 WO disclosed
US-20040082066-A1 Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis CYTOVIA, INC. 2004-04-29 US disclosed
WO-2004002428-A2 DERIVATIVES OF GAMBOGIC ACID AND INDUCE APOPTOSIS CYTOVIA, INC. (US) 2004-01-08 WO disclosed
US-6613762-B2 Synergystic mixtures comprising prodrugs, 9,10-dihydrogambogic acid and antibodies, cell growth factors or cytokines, used as anticarcinogenic agents CYTOVIA, INC. 2003-09-02 US disclosed
US-20030078292-A1 Gambogic acid, analogs and derivatives as activators of caspases and inducers of apoptosis CYTOVIA, INC. 2003-04-24 US disclosed
US-6462041-B1 ACTIVATORS OF CASPASE CASCADE; TREATING, PREVENTING OR AMELIORATING NEOPLASIA AND CANCER CYTOVIA, INC. 2002-10-08 US disclosed
EP-1180991-A2 GAMBOGIC ACID, ANALOGS AND DERIVATIVES AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS Cytovia, Inc. (US) 2002-02-27 EP disclosed
WO-2000044216-A2 GAMBOGIC ACID, ANALOGS AND DERIVATIVES AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS CYTOVIA INC (US) 2000-08-03 WO disclosed